Bipolar depression market

View All

fanapt-for-bipolar-disorder-treatment
Vanda Broadens its Reach to Bipolar Disorder Treatment Market With Fanapt Approval

Fifteen years after its first FDA approval for treating schizophrenia with Fanapt (iloperidone), Vanda Pharmaceuticals has achieved another success. Fanapt is a type of antipsychotic medication that deviates from the usual and has been administered to individuals with schizophrenia for their immediate treatment fol...

Find More

Bipolar Depression Market |Bipolar Depression Pipeline
Watch Out For Top Pipeline Therapies Making An Impact In The Bipolar Depression Market

Characterized by debilitating episodes of depression and mood elevation (mania or hypomania), Bipolar depression is an under-recognized and unappreciated phase of bipolar disorder. Since most patients exhibit depression, Bipolar depression gets misdiagnosed with other mental disorders easily. Thus, it is associated...

Find More